These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 29112233)

  • 1. Neuroendocrine tumors and fibrosis: An unsolved mystery?
    Laskaratos FM; Rombouts K; Caplin M; Toumpanakis C; Thirlwell C; Mandair D
    Cancer; 2017 Dec; 123(24):4770-4790. PubMed ID: 29112233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic Factors for Survival among Patients with Small Bowel Neuroendocrine Tumours Associated with Mesenteric Desmoplasia.
    Laskaratos FM; Diamantopoulos L; Walker M; Walton H; Khalifa M; El-Khouly F; Koffas A; Demetriou G; Caplin M; Toumpanakis C; Mandair D
    Neuroendocrinology; 2018; 106(4):366-380. PubMed ID: 29320779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Neuroendocrine tumors of the kidneys].
    Moch H
    Pathologe; 2015 May; 36(3):278-82. PubMed ID: 25898936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carcinoid tumors and fibrosis: an association with no explanation.
    Modlin IM; Shapiro MD; Kidd M
    Am J Gastroenterol; 2004 Dec; 99(12):2466-78. PubMed ID: 15571597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Tumor Microenvironment in Neuroendocrine Tumors: Biology and Therapeutic Implications.
    Cives M; Pelle' E; Quaresmini D; Rizzo FM; Tucci M; Silvestris F
    Neuroendocrinology; 2019; 109(2):83-99. PubMed ID: 30699437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What Causes Desmoplastic Reaction in Small Intestinal Neuroendocrine Neoplasms?
    Ratnayake GM; Laskaratos FM; Mandair D; Caplin ME; Rombouts K; Toumpanakis C
    Curr Oncol Rep; 2022 Oct; 24(10):1281-1286. PubMed ID: 35554845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small intestinal neuroendocrine tumours and fibrosis: an entangled conundrum.
    Blažević A; Hofland J; Hofland LJ; Feelders RA; de Herder WW
    Endocr Relat Cancer; 2018 Mar; 25(3):R115-R130. PubMed ID: 29233841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological and molecular aspects of gastroenteropancreatic neuroendocrine tumors.
    Rindi G; Villanacci V; Ubiali A
    Digestion; 2000; 62 Suppl 1():19-26. PubMed ID: 10940683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and biochemical aspects of the carcinoid syndrome in neuroendocrine tumors of the abdominal and retroperitoneal organs and its impact for the disease prognosis.
    Polikarpova SB; Lubimova NV; Ogereliev AS; Britvin TA; Davidov MI
    Bull Exp Biol Med; 2009 Nov; 148(5):803-6. PubMed ID: 20396797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Epithelial neuroendocrine tumors of the upper respiratory tract: New entities, new perspectives].
    Brobeil A; Dreyer T; Schäffer R; Bräuninger A; Gattenlöhner S
    Pathologe; 2015 May; 36(3):271-7. PubMed ID: 25963713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Algorithmic approach to neuroendocrine tumors in targeted biopsies: Practical applications of immunohistochemical markers.
    Duan K; Mete O
    Cancer Cytopathol; 2016 Dec; 124(12):871-884. PubMed ID: 27529763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical signs of fibrosis in small intestinal neuroendocrine tumours.
    Daskalakis K; Karakatsanis A; Stålberg P; Norlén O; Hellman P
    Br J Surg; 2017 Jan; 104(1):69-75. PubMed ID: 27861745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histologic changes in type A chronic atrophic gastritis indicating increased risk of neuroendocrine tumor development: the predictive role of dysplastic and severely hyperplastic enterochromaffin-like cell lesions.
    Vanoli A; La Rosa S; Luinetti O; Klersy C; Manca R; Alvisi C; Rossi S; Trespi E; Zangrandi A; Sessa F; Capella C; Solcia E
    Hum Pathol; 2013 Sep; 44(9):1827-37. PubMed ID: 23642738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroendocrine neoplasms of the larynx: an overview.
    Ferlito A; Silver CE; Bradford CR; Rinaldo A
    Head Neck; 2009 Dec; 31(12):1634-46. PubMed ID: 19536850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CDX2 may be a useful marker to distinguish primary ovarian carcinoid from gastrointestinal metastatic carcinoids to the ovary.
    Desouki MM; Lioyd J; Xu H; Cao D; Barner R; Zhao C
    Hum Pathol; 2013 Nov; 44(11):2536-41. PubMed ID: 24029704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tangled fibroblasts in tumor-stroma interactions.
    Liu M; Xu J; Deng H
    Int J Cancer; 2011 Oct; 129(8):1795-805. PubMed ID: 21469145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [What is new in the pathology of pancreatic neuroendocrine tumors?].
    Komminoth P; Perren A
    Pathologe; 2015 May; 36(3):220-8. PubMed ID: 25941099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [New prognostic and predictive markers for breast cancer].
    Wachter DL
    Pathologe; 2016 Nov; 37(Suppl 2):217-222. PubMed ID: 27638528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Symptoms and diagnostics of lung neuroendocrine tumors].
    Tamási L; Müller V
    Orv Hetil; 2011 Mar; 152(10):366-70. PubMed ID: 21354952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroendocrine neoplasms of the larynx.
    Overholt SM; Donovan DT; Schwartz MR; Laucirica R; Green LK; Alford BR
    Laryngoscope; 1995 Aug; 105(8 Pt 1):789-94. PubMed ID: 7630288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.